{"\\NHLBI TOPMed: Novel Risk Factors for the Development of Atrial Fibrillation in Women\\Laboratory Measurements\\Apo A1\\": "All NaN", "\\NHLBI TOPMed: Novel Risk Factors for the Development of Atrial Fibrillation in Women\\Laboratory Measurements\\Apo B\\": "All NaN", "\\NHLBI TOPMed: Novel Risk Factors for the Development of Atrial Fibrillation in Women\\Laboratory Measurements\\Baseline blood draw at least 8 hours after last meal\\": "All NaN", "\\NHLBI TOPMed: Novel Risk Factors for the Development of Atrial Fibrillation in Women\\Laboratory Measurements\\CRP(Denka)\\": "All NaN", "\\NHLBI TOPMed: Novel Risk Factors for the Development of Atrial Fibrillation in Women\\Laboratory Measurements\\Creatinine\\": "All NaN", "\\NHLBI TOPMed: Novel Risk Factors for the Development of Atrial Fibrillation in Women\\Laboratory Measurements\\Diastolic blood pressure\\": "All NaN", "\\NHLBI TOPMed: Novel Risk Factors for the Development of Atrial Fibrillation in Women\\Laboratory Measurements\\Fibrinogen\\": "All NaN", "\\NHLBI TOPMed: Novel Risk Factors for the Development of Atrial Fibrillation in Women\\Laboratory Measurements\\HDL cholesterol in mg/dl at baseline\\": "All NaN", "\\NHLBI TOPMed: Novel Risk Factors for the Development of Atrial Fibrillation in Women\\Laboratory Measurements\\HbA1c\\": "All NaN", "\\NHLBI TOPMed: Novel Risk Factors for the Development of Atrial Fibrillation in Women\\Laboratory Measurements\\Homocysteine\\": "All NaN", "\\NHLBI TOPMed: Novel Risk Factors for the Development of Atrial Fibrillation in Women\\Laboratory Measurements\\ICAM\\": "All NaN", "\\NHLBI TOPMed: Novel Risk Factors for the Development of Atrial Fibrillation in Women\\Laboratory Measurements\\LDL cholesterol in mg/dl at baseline, direct measure\\": "All NaN", "\\NHLBI TOPMed: Novel Risk Factors for the Development of Atrial Fibrillation in Women\\Laboratory Measurements\\Lp(a)\\": "All NaN", "\\NHLBI TOPMed: Novel Risk Factors for the Development of Atrial Fibrillation in Women\\Laboratory Measurements\\Principal Components\\Principal component 10\\": "All NaN", "\\NHLBI TOPMed: Novel Risk Factors for the Development of Atrial Fibrillation in Women\\Laboratory Measurements\\Principal Components\\Principal component 1\\": "All NaN", "\\NHLBI TOPMed: Novel Risk Factors for the Development of Atrial Fibrillation in Women\\Laboratory Measurements\\Principal Components\\Principal component 2\\": "All NaN", "\\NHLBI TOPMed: Novel Risk Factors for the Development of Atrial Fibrillation in Women\\Laboratory Measurements\\Principal Components\\Principal component 3\\": "All NaN", "\\NHLBI TOPMed: Novel Risk Factors for the Development of Atrial Fibrillation in Women\\Laboratory Measurements\\Principal Components\\Principal component 4\\": "All NaN", "\\NHLBI TOPMed: Novel Risk Factors for the Development of Atrial Fibrillation in Women\\Laboratory Measurements\\Principal Components\\Principal component 5\\": "All NaN", "\\NHLBI TOPMed: Novel Risk Factors for the Development of Atrial Fibrillation in Women\\Laboratory Measurements\\Principal Components\\Principal component 6\\": "All NaN", "\\NHLBI TOPMed: Novel Risk Factors for the Development of Atrial Fibrillation in Women\\Laboratory Measurements\\Principal Components\\Principal component 7\\": "All NaN", "\\NHLBI TOPMed: Novel Risk Factors for the Development of Atrial Fibrillation in Women\\Laboratory Measurements\\Principal Components\\Principal component 8\\": "All NaN", "\\NHLBI TOPMed: Novel Risk Factors for the Development of Atrial Fibrillation in Women\\Laboratory Measurements\\Principal Components\\Principal component 9\\": "All NaN", "\\NHLBI TOPMed: Novel Risk Factors for the Development of Atrial Fibrillation in Women\\Laboratory Measurements\\Systolic blood pressure\\": "All NaN", "\\NHLBI TOPMed: Novel Risk Factors for the Development of Atrial Fibrillation in Women\\Laboratory Measurements\\Total cholesterol at baseline\\": "All NaN", "\\NHLBI TOPMed: Novel Risk Factors for the Development of Atrial Fibrillation in Women\\Laboratory Measurements\\Triglycerides in mg/dl at baseline\\": "All NaN", "\\NHLBI TOPMed: Novel Risk Factors for the Development of Atrial Fibrillation in Women\\Lifestyle and Environment\\Alcohol use\\": "All NaN", "\\NHLBI TOPMed: Novel Risk Factors for the Development of Atrial Fibrillation in Women\\Lifestyle and Environment\\Cholesterol lowering medication at baseline\\": "All NaN", "\\NHLBI TOPMed: Novel Risk Factors for the Development of Atrial Fibrillation in Women\\Lifestyle and Environment\\Exercise\\": "All NaN", "\\NHLBI TOPMed: Novel Risk Factors for the Development of Atrial Fibrillation in Women\\Lifestyle and Environment\\Smoking status\\": "All NaN", "\\NHLBI TOPMed: Novel Risk Factors for the Development of Atrial Fibrillation in Women\\Physical Observations\\Age at AF diagnosis\\": "All NaN", "\\NHLBI TOPMed: Novel Risk Factors for the Development of Atrial Fibrillation in Women\\Physical Observations\\Age at enrollment\\": "All NaN", "\\NHLBI TOPMed: Novel Risk Factors for the Development of Atrial Fibrillation in Women\\Physical Observations\\Age at menarche\\": "All NaN", "\\NHLBI TOPMed: Novel Risk Factors for the Development of Atrial Fibrillation in Women\\Physical Observations\\Age at menopause\\": "All NaN", "\\NHLBI TOPMed: Novel Risk Factors for the Development of Atrial Fibrillation in Women\\Physical Observations\\Body mass index\\": "All NaN", "\\NHLBI TOPMed: Novel Risk Factors for the Development of Atrial Fibrillation in Women\\Physical Observations\\Diabetes at baseline\\": "All NaN", "\\NHLBI TOPMed: Novel Risk Factors for the Development of Atrial Fibrillation in Women\\Physical Observations\\Height\\": "All NaN", "\\NHLBI TOPMed: Novel Risk Factors for the Development of Atrial Fibrillation in Women\\Physical Observations\\Metabolic syndrome\\": "All NaN", "\\NHLBI TOPMed: Novel Risk Factors for the Development of Atrial Fibrillation in Women\\Physical Observations\\Uterine fibroids\\": "All NaN", "\\NHLBI TOPMed: Novel Risk Factors for the Development of Atrial Fibrillation in Women\\Physical Observations\\Waist/hip ratio\\": "All NaN", "\\NHLBI TOPMed: Novel Risk Factors for the Development of Atrial Fibrillation in Women\\Physical Observations\\Weight\\": "All NaN", "\\NHLBI TOPMed: Novel Risk Factors for the Development of Atrial Fibrillation in Women\\Sample Attributes\\TOPMed Phase\\": "All NaN"}